Abstract
Suicide is the tenth leading cause of death in Americans of all ages. Presence of a chronic medical illness (e.g. Diabetes mellitus) increases the risk of suicide. The goal of this review is to examine the relationship between diabetes and depression, as well as diabetes and suicide. Earlier this year, the U.S. Preventive Task Force (USPTF) escalated their recommendation for depression to include not only routine screening for depression but additional focus on active follow up that requires measurement based care. As a result, it is important that persons with diabetes are also screened for suicidal ideation in the presence of a mood disorder. Due to the higher risk and access to potentially lethal medications in persons with diabetes, risk mitigation procedures should be in place that includes not only depression and suicide screening but also the use of inter-disciplinary teams. Appropriate medical monitoring is essential following a suicide attempt to avoid death particularly because these patients are prone to repeat attempts.
Keywords: Depression, diabetes, insulin pump, suicide attempt, overdose.
Current Diabetes Reviews
Title:Death by Insulin: Management of Self-Harm and Suicide in Diabetes Management
Volume: 13 Issue: 3
Author(s): Alyson K. Myers*Madhukar H. Trivedi
Affiliation:
- North Shore University Hospital and Assistant Professor Hofstra Northwell School of Medicine, Hempstead, NY, 300 Community Drive, Manhasset, NY, 11030,United States
Keywords: Depression, diabetes, insulin pump, suicide attempt, overdose.
Abstract: Suicide is the tenth leading cause of death in Americans of all ages. Presence of a chronic medical illness (e.g. Diabetes mellitus) increases the risk of suicide. The goal of this review is to examine the relationship between diabetes and depression, as well as diabetes and suicide. Earlier this year, the U.S. Preventive Task Force (USPTF) escalated their recommendation for depression to include not only routine screening for depression but additional focus on active follow up that requires measurement based care. As a result, it is important that persons with diabetes are also screened for suicidal ideation in the presence of a mood disorder. Due to the higher risk and access to potentially lethal medications in persons with diabetes, risk mitigation procedures should be in place that includes not only depression and suicide screening but also the use of inter-disciplinary teams. Appropriate medical monitoring is essential following a suicide attempt to avoid death particularly because these patients are prone to repeat attempts.
Export Options
About this article
Cite this article as:
Myers K. Alyson*, Trivedi H. Madhukar, Death by Insulin: Management of Self-Harm and Suicide in Diabetes Management, Current Diabetes Reviews 2017; 13 (3) . https://dx.doi.org/10.2174/1573399812666161005163618
DOI https://dx.doi.org/10.2174/1573399812666161005163618 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Preface
Current Nutrition & Food Science A Pilot Study of Exenatide Actions in Alzheimer’s Disease
Current Alzheimer Research Editorial: Oxidative Stress in Pathophysiological Conditions
Current Vascular Pharmacology Clinical Research on the Aortic Elasticity in Patients with Type 1 Diabetes Mellitus Complicated with Hypertension
Current Medical Imaging Anti-VEGF Therapy for Retinal Vein Occlusions
Current Drug Targets Proteomics Approaches to Understand Linkage Between Alzheimer’s Disease and Type 2 Diabetes Mellitus
CNS & Neurological Disorders - Drug Targets The Role of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Cardiovascular Homeostasis: A Non-Systematic Literature Review
Current Cardiology Reviews Endocannabinoid Receptor Antagonists and Other Emerging Pharmacological Strategies for Weight Reduction
Current Drug Targets - Cardiovascular & Hematological Disorders Targeting Metabolic Enzymes in Cancer – Clinical Trials Update
Current Enzyme Inhibition Enriching One’s Environment in the Face of Cognitive and Functional Loss
Current Neurovascular Research Systems Biology of HBOC-Induced Vasoconstriction
Current Drug Discovery Technologies Endothelial Function Assessment in Complicated Hypertension
Current Pharmaceutical Design Effects of Metformin-Single Therapy on the Level of Inflammatory Markers in Serum of Non-Obese T2DM Patients with NAFLD
Endocrine, Metabolic & Immune Disorders - Drug Targets A Diabetes Treatment Strategy to Reduce the Risk of Cardiovascular Events: Clinical Benefits and Potential of Linagliptin
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Glycation and Hypoxia: Two Key Factors for Adipose Tissue Dysfunction
Current Medicinal Chemistry Programming Apoptosis and Autophagy with Novel Approaches for Diabetes Mellitus
Current Neurovascular Research Caffeine and Suicide: A Systematic Review
CNS & Neurological Disorders - Drug Targets Glycation Induced Generation of Amyloid Fibril Structures by Glucose Metabolites
Protein & Peptide Letters Nab-Paclitaxel in Metastatic Breast Cancer: Defining the Best Patient Profile
Current Cancer Drug Targets Putting Evidence for Diabetes Care into Practice
Current Diabetes Reviews